NO20050766L - Sulfonylpiperidinderivater som inneholder en aryl- eller heteroarylgruppe til anvendelse som matriksmetalloproteinaseinhibitor - Google Patents
Sulfonylpiperidinderivater som inneholder en aryl- eller heteroarylgruppe til anvendelse som matriksmetalloproteinaseinhibitorInfo
- Publication number
- NO20050766L NO20050766L NO20050766A NO20050766A NO20050766L NO 20050766 L NO20050766 L NO 20050766L NO 20050766 A NO20050766 A NO 20050766A NO 20050766 A NO20050766 A NO 20050766A NO 20050766 L NO20050766 L NO 20050766L
- Authority
- NO
- Norway
- Prior art keywords
- heteroaryl group
- aryl
- sulfonylpiperidine
- matrix metalloproteinase
- derivatives containing
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/92—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with a hetero atom directly attached to the ring nitrogen atom
- C07D211/96—Sulfur atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Transplantation (AREA)
- Pulmonology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Plural Heterocyclic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0216383.0A GB0216383D0 (en) | 2002-07-13 | 2002-07-13 | Compounds |
| PCT/GB2003/002982 WO2004006926A1 (en) | 2002-07-13 | 2003-07-09 | Sulphonylpiperidine derivatives containing an aryl or heteroaryl group for use as matrix metalloproteinase inhibitors |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO20050766L true NO20050766L (no) | 2005-04-11 |
Family
ID=9940463
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20050766A NO20050766L (no) | 2002-07-13 | 2005-02-11 | Sulfonylpiperidinderivater som inneholder en aryl- eller heteroarylgruppe til anvendelse som matriksmetalloproteinaseinhibitor |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US20060173041A1 (is) |
| EP (1) | EP1539159A1 (is) |
| JP (1) | JP2006501192A (is) |
| CN (1) | CN1681503A (is) |
| AU (1) | AU2003254441A1 (is) |
| BR (1) | BR0312620A (is) |
| CA (1) | CA2492086A1 (is) |
| GB (1) | GB0216383D0 (is) |
| IL (1) | IL165976A0 (is) |
| IS (1) | IS7688A (is) |
| MX (1) | MXPA05000519A (is) |
| NO (1) | NO20050766L (is) |
| PL (1) | PL375362A1 (is) |
| RU (1) | RU2004138546A (is) |
| WO (1) | WO2004006926A1 (is) |
| ZA (1) | ZA200500208B (is) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2319970T3 (es) | 2001-09-07 | 2009-05-18 | Kaken Pharmaceutical Co., Ltd. | Derivados de acido hidroxamico inverso. |
| EP1828160B1 (en) | 2004-12-21 | 2011-12-14 | Merck Serono SA | Sulfonyl amino cyclic derivatives and use thereof as mmp inhibitors |
| JP5203956B2 (ja) * | 2005-10-26 | 2013-06-05 | メルク セローノ ソシエテ アノニム | メタロプロテイナーゼの調節のためのスルホンアミド誘導体とその使用 |
| CN102459177B (zh) * | 2009-04-22 | 2015-09-02 | 埃克希金医药品有限公司 | 2,5-二取代的芳基磺酰胺ccr3拮抗剂 |
| EP2554544A1 (en) | 2011-08-01 | 2013-02-06 | Almirall, S.A. | Pyridin-2(1h)-one derivatives as jak inhibitors |
| TWI679205B (zh) | 2014-09-02 | 2019-12-11 | 日商日本新藥股份有限公司 | 吡唑并噻唑化合物及醫藥 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1985003707A1 (en) * | 1984-02-15 | 1985-08-29 | Schering Corporation | 8-CHLORO-6,11-DIHYDRO-11-(4-PIPERIDYLIDENE)-5H-BENZO AD5,6 BDCYCLOHEPTA AD1,2-b BDPYRIDINE AND ITS SALTS, PROCESSES FOR THE PRODUCTION THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING THESE COMPOUNDS |
| WO1999024399A1 (en) * | 1997-11-12 | 1999-05-20 | Darwin Discovery Limited | Hydroxamic and carboxylic acid derivatives having mmp and tnf inhibitory activity |
| EP1107953A1 (en) * | 1998-08-29 | 2001-06-20 | British Biotech Pharmaceuticals Limited | Hydroxamic acid derivatives as proteinase inhibitors |
| GB9919776D0 (en) * | 1998-08-31 | 1999-10-27 | Zeneca Ltd | Compoujnds |
| CA2409035A1 (en) * | 2000-05-15 | 2001-11-22 | Darwin Discovery Limited | Hydroxamic acid derivatives |
-
2002
- 2002-07-13 GB GBGB0216383.0A patent/GB0216383D0/en not_active Ceased
-
2003
- 2003-07-09 EP EP03763980A patent/EP1539159A1/en not_active Withdrawn
- 2003-07-09 PL PL03375362A patent/PL375362A1/xx not_active Application Discontinuation
- 2003-07-09 JP JP2004520835A patent/JP2006501192A/ja active Pending
- 2003-07-09 US US10/520,861 patent/US20060173041A1/en not_active Abandoned
- 2003-07-09 MX MXPA05000519A patent/MXPA05000519A/es not_active Application Discontinuation
- 2003-07-09 CA CA002492086A patent/CA2492086A1/en not_active Abandoned
- 2003-07-09 CN CNA038216175A patent/CN1681503A/zh active Pending
- 2003-07-09 RU RU2004138546/04A patent/RU2004138546A/ru not_active Application Discontinuation
- 2003-07-09 BR BR0312620-0A patent/BR0312620A/pt not_active Application Discontinuation
- 2003-07-09 WO PCT/GB2003/002982 patent/WO2004006926A1/en not_active Application Discontinuation
- 2003-07-09 AU AU2003254441A patent/AU2003254441A1/en not_active Abandoned
-
2004
- 2004-12-23 IL IL16597604A patent/IL165976A0/xx unknown
-
2005
- 2005-01-10 ZA ZA200500208A patent/ZA200500208B/en unknown
- 2005-02-08 IS IS7688A patent/IS7688A/is unknown
- 2005-02-11 NO NO20050766A patent/NO20050766L/no unknown
Also Published As
| Publication number | Publication date |
|---|---|
| US20060173041A1 (en) | 2006-08-03 |
| AU2003254441A1 (en) | 2004-02-02 |
| WO2004006926A1 (en) | 2004-01-22 |
| JP2006501192A (ja) | 2006-01-12 |
| GB0216383D0 (en) | 2002-08-21 |
| IS7688A (is) | 2005-02-08 |
| PL375362A1 (en) | 2005-11-28 |
| BR0312620A (pt) | 2005-04-26 |
| CA2492086A1 (en) | 2004-01-22 |
| IL165976A0 (en) | 2006-01-15 |
| ZA200500208B (en) | 2005-10-20 |
| MXPA05000519A (es) | 2005-03-23 |
| RU2004138546A (ru) | 2005-09-10 |
| CN1681503A (zh) | 2005-10-12 |
| EP1539159A1 (en) | 2005-06-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20051600L (no) | 1,4-disubstituerte piperidinderivater og anvendelse derav som 11-betaHSD1 inhibitorer | |
| DE69809187T2 (de) | Metalloproteinase-Inhibitoren | |
| NO20052887L (no) | Pyridazinonderivater som GSK-3Beta inhibitorer. | |
| NO20050199L (no) | Azadisyklo-oktan og nonanderivater med DDP-IV-inhiberende aktivitet | |
| NO20043587L (no) | Nye heterocykliske forbindelser som er aktive som inhibitorer av beta-laktamaser | |
| DE69431718T2 (de) | Thrombin-inhibitoren | |
| NO20051695L (no) | Nye spirokondenserte kinazolinoner og deres anvendelse som fosfodiestereaseinbibitorer | |
| NO20050766L (no) | Sulfonylpiperidinderivater som inneholder en aryl- eller heteroarylgruppe til anvendelse som matriksmetalloproteinaseinhibitor | |
| TR200100605T2 (tr) | Arilpiperazinler ve bunların metaloproteinaz inhibe edici maddeler (MMP) olarak kullanımı | |
| NO986180L (no) | Nye amidinoderivater og deres anvendelse som trombininhibitorer | |
| NO20050065L (no) | Kjemiske forbindelser | |
| NO20063090L (no) | Amidopyrazolderivater | |
| DK1001930T3 (da) | N-hydroxyformamidderivater som inhibitorer af matrix-metalloproteinaser | |
| NZ529874A (en) | Aromatic dicarboxylic acid derivatives useful as HDAC inhibitors | |
| DK0892780T3 (da) | m-Amidinophenylanaloger som faktor Xa-inhibitorer | |
| NO20006282L (no) | Nye cyklosporiner | |
| NO20054787D0 (no) | Indenderivater som farmasotiske midler | |
| NO963370L (no) | Nye mercaptoacetylamido-1,3,4,5-tetrahydrobenzo[cÅazepin-3-on-disulfidderivater som er anvendbare som inhibitorer av enkefalinase og ACE | |
| ATE235462T1 (de) | Metalloproteinase-inhibitoren | |
| PA8586801A1 (es) | Inhibidores de hiv-integrasa, composiciones farmaceuticas y metodos para su uso | |
| NO20013675L (no) | 2,3,4,5-tetrahydro-1H-[1,4)benzodiazepin-3-hydroksamsyre som matriks-metalloproteinase-inhibitorer | |
| SE0103710D0 (sv) | Compounds | |
| WO2003016248A3 (en) | Bicyclic hydroxamates as inhibitors of matrix metalloproteinases and/or tnf-$g(a) converting enzyme (tace) | |
| WO2004030664A3 (en) | New compounds for the inhibition of undesired cell proliferation and use thereof | |
| NO20050765L (no) | N-sulfonylpiperidiner som metalloproteinaseinhibitorer (TACE) |